5 Best Dialysis and Kidney Disease Stocks to Buy

3. The Cigna Group (NYSE:CI)

Number of Hedge Fund Holders In Q2 2023: 74

Market Capitalization: $92.1 Billion

The Cigna Group (NYSE:CI) was founded more than 200 years ago and is headquartered in Bloomfield, Connecticut. With a market capitalization of $92.1 billion, The Cigna Group (NYSE:CI) ranks 3rd in our list of the best dialysis and kidney disease stocks to buy. With a huge presence in the US, the company provides staff-assisted home hemodialysis services too for its patients. The Cigna Group (NYSE:CI) launched a Cigna Collaborative Care program for chronic kidney disease in 2016. It reported Q2 revenue of $48.6 billion and EPS of $6.13, beating analysts’ expectations of $5.98.

Insider Monkey’s research of Q2 2023 covering 910 hedge funds showed that 74 had owned The Cigna Group (NYSE:CI)’s shares. The firm’s largest stakeholder among these is Larry Robbins’ Glenview Capital as it owns $579.6 million worth of shares.